SEC Form 4 · accession 0001144204-15-071682
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marek Biestek
Director · Other
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 16, 2015 | P | 10,000 | $29.32 | A | 250,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Marek Biestek acquired 10,000 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Marek Biestek in the transaction was $293,200.
- F2The securities reported herein are owned directly by Marek Biestek, who is a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934. Marek Biestek individually owns less than 10%. There is no voting or ownership agreement amongst the group members and the other members of the group do not have a pecuniary interest in the shares reported herein. Correspondingly, Mr. Biestek does not have a pecuniary interest in the shares owned by the other members of the group.
Remarks
Marek Biestek is a member of a "group" for purposes of Section 13(d) of the Exchange Act of 1934, but individually owns less than 10%.